Published in Arthritis Res on February 09, 2000
Nitric oxide-driven hypoxia initiates synovial angiogenesis, hyperplasia and inflammatory lesions in mice. PLoS One (2012) 0.83
21st European Workshop for Rheumatology Research, Vienna, Austria, 1-4 March 2001. Arthritis Res (2001) 0.75
Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J (1991) 8.31
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest (1998) 6.92
Organ-specific disease provoked by systemic autoimmunity. Cell (1996) 6.44
The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol (1973) 5.64
From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity (1999) 5.38
Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science (1999) 4.97
The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol (1999) 3.22
Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum (1989) 1.95
DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition. J Immunol (1997) 1.52
The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol (1994) 1.47
The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis. Arthritis Rheum (1999) 1.19
Transfusion studies in rheumatoid arthritis. Arthritis Rheum (1961) 1.15
Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum (1986) 1.11
Rheumatoid arthritis and its animal models: the role of TNF-alpha and the possible absence of specific immune reactions. Curr Opin Immunol (1999) 1.05
Fistula of the thoracic duct as immunosuppressive treatment in rheumatoid arthritis. Acta Med Scand (1970) 1.05
Evaluating candidate autoantigens in rheumatoid arthritis. Springer Semin Immunopathol (1998) 0.89